A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study With Double-Blind Extension to Assess the Efficacy and Safety of Vamorolone in Ambulant Boys With Duchenne Muscular Dystrophy (DMD)
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2018
At a glance
- Drugs Vamorolone (Primary) ; Prednisone
- Indications Duchenne muscular dystrophy
- Focus Therapeutic Use
- Acronyms VISION DMD
- Sponsors ReveraGen BioPharma
- 20 Jun 2018 Status changed from not yet recruiting to recruiting.
- 09 Apr 2018 Planned initiation date changed from 15 Mar 2018 to 30 Apr 2018.
- 19 Feb 2018 Status changed from planning to not yet recruiting.